| Literature DB >> 31835660 |
Junior Mudji1,2, Jonathan Benhamou3,4, Erick Mwamba-Miaka5, Christian Burri3,4, Johannes Blum1,3,4.
Abstract
Human African Trypanosomiasis (HAT) is a neglected disease caused by the protozoan parasites Trypanosoma brucei and transmitted by tsetse flies that progresses in two phases. Symptoms in the first phase include fever, headaches, pruritus, lymphadenopathy, and in certain cases, hepato- and splenomegaly. Neurological disorders such as sleep disorder, aggressive behavior, logorrhea, psychotic reactions, and mood changes are signs of the second stage of the disease. Diagnosis follows complex algorithms, including serological testing and microscopy. Our case report illustrates the course of events of a 41-year old woman with sleep disorder, among other neurological symptoms, whose diagnosis was made seven months after the onset of symptoms. The patient had consulted two different hospitals in Kinshasa and was on the verge of being discharged from a third due to negative laboratory test results. This case report highlights the challenges that may arise when a disease is on the verge of eradication.Entities:
Keywords: Human African Trypanosomiasis (HAT); eradication; mydriasis; neurological signs; re-emergence
Year: 2019 PMID: 31835660 PMCID: PMC6958452 DOI: 10.3390/tropicalmed4040142
Source DB: PubMed Journal: Trop Med Infect Dis ISSN: 2414-6366
Figure 1Areflective bilateral mydriasis in HAT patient.
Figure 2The same HAT patients at the end of treatment with normal pupillary reaction.
Figure 3Overview of new HAT cases in the DRC from 1926-2018. Figure from the Programme National de Lutte contre la Trypanosomiase Humaine Africaine (PNLTHA), Kinshasa, DR of Congo, 2018.